Clinical Trial Update: Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER) [Phase 2]

View source ↗

Summary

Phase II trial RANGER evaluates PSA-response-guided androgen deprivation therapy with nodal coverage for early salvage radiotherapy in prostate cancer. Recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING